Oxitec
Company Details
Status: Private
Employees: 101-250
Location:
Abingdon, United Kingdom
Type:
sample
Technology:
About: Using advanced genetics and molecular biologyOxitechas developed a new and innovative solution to controlling the dangerous mosquito, Aedes aegypti.The Oxitec solution harnesses the natural instincts of male mosquitoes to find females in the wild. Oxitec has used genetic engineering to create ‘self-limiting’ male insects which seek out and mate with females. After an Oxitec male mosquito has successfully mated with a wild female, any offspring that result will not survive to adulthood, so the mosquito population declines.The Oxitec Control Programme is the system through which Oxitec mosquitoes are released and monitored over a predetermined and sustained period of time in an area with Aedes aegypti mosquitoes. By applying the Oxitec Control Programme to an area, the mosquito population in that area can be dramatically reduced or eliminated.Unlike conventional insecticides or pesticides, which kill insects indiscriminately, the Oxitec approach is targeted at a single species. This means that, as well as being more effective, it is much better for the environment than conventional tools.Oxitec is a subsidiary ofIntrexon Corporation (NYSE: XON), which engineers biology to help solve some of the world’s biggest problems.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Oxitec | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.